Convicted intercourse offender Jeffrey Epstein paid for genetic testing in an apparent bid to harness his personal genetic materials for regenerative medication – which is aimed toward repairing the physique by creating new tissues and organs because the outdated ones put on out – in accordance to newly launched emails in the Epstein information.
Several years after Epstein was initially convicted on prostitution-related prices in 2008, he paid for novel checks from a health care provider at one in every of America’s preeminent hospitals and explored creating stem cells central to immunity and therapeutic.
The researcher, Joseph Thakuria, was on the time a senior physician at Massachusetts General Hospital (MGH) in Boston and affiliated with a large-scale genomic research challenge at Harvard Medical School.
In an announcement to NCS, Thakuria mentioned Epstein was additionally enrolled in the Harvard Personal Genome Project, a large public world database of genetic data from volunteers for scientists and researchers to be taught extra about traits and genes.
Thakuria has not been publicly linked to Epstein earlier than and isn’t accused of any wrongdoing.
A Harvard consultant mentioned MGH is an affiliate of Harvard, however Thakuria was indirectly employed by Harvard or the Wyss Institute, which oversees the Personal Genome Project. MGH has no file of approving Thakuria for research described in the Epstein emails.
Thakuria left the hospital in 2022, an MGH spokesperson mentioned.
Among the paperwork in the Epstein information launched by the Justice Department is a proposal that Thakuria despatched Epstein in February 2014, interesting to him to fund a non-public challenge that may sequence his sufferers’ genomes to find out about genetic drivers for their ailments. In the proposal, he additionally raises choices for genetic investigations particularly for Epstein.
A number of months later, in June, Thakuria despatched Epstein an extensive invoice for a spread of initiatives that included an preliminary $2,000 funding for sequencing a part of Epstein’s genome. The bill included an estimated price for “personalized longevity studies” that proposed utilizing gene enhancing. The bill indicated that Epstein gave a saliva pattern.
The preliminary funding included $1,000 to sequence a portion of his genome often known as the exome, and $1,000 to sequence fibroblasts, that are cells discovered in connective tissue corresponding to pores and skin and muscle groups, and which have been used in a comparatively new area of analysis aimed toward reversing growing older.
Epstein’s workers despatched a $2,000 test the identical day.
“Mr. Epstein was enrolled in the Personal Genome Project, which would study his genetic predisposition to various health conditions. At one point, a $2,000 check was provided to cover DNA sequencing,” Thakuria mentioned in the assertion.
“I was a physician-researcher and he [Epstein] was a research subject,” he added. “We also had early discussions about his potentially funding research, but that never materialized.”
“I feel terrible about what his victims went through, and I regret at that time not knowing more about his background and the extent of his crimes,” Thakuria mentioned.
Part of the proposal concerned enhancing Epstein’s stem cells “to introduce mutations in culture believed to increase longevity,” utilizing the then-novel gene enhancing know-how CRISPR, Thakuria wrote.
“I’m only offering this to Jeffrey. Because of all the labor involved, there’s simply not enough bandwidth to offer this to more than a handful of people right now,” he added.
The bill gave a spread of choices for future analysis corresponding to creating new stem cells beginning at $10,000, and broader longevity research that included different sufferers, and indicated that it might price “$11,400 for his [Epstein’s] whole genome ($21,000 if he wanted to include both of his parents; not sure if this is even feasible)” to be sequenced.
The full breadth of the initiatives proposed as described in the bill would have price $193,400.
NCS didn’t discover a file of Epstein paying for these companies, however emails continued between Thakuria, Epstein and his assistants till a minimum of 2015. In these, Epstein’s assistants sought to comply with up on Thakuria’s preliminary work. At one level, Epstein turned irritated with Thakuria for delays and threatened to report him to his bosses if outcomes didn’t come rapidly.
Epstein died by suicide in 2019 whereas awaiting trial on federal sex-trafficking prices.
The disgraced financier had lengthy been in gene enhancing. Through his now-defunct basis, Epstein donated to the World Transhumanist Association, now referred to as Humanity+, because the New York Times first reported in 2019. Humanity+ advocates for “technology and evidence-based science to expand human capabilities” and reverse growing older.
Epstein additionally reportedly had discussions with scientists the place he mulled utilizing his personal genes to seed a new human race.
The most just lately launched emails shed new gentle on Epstein’s relationships with high scientists in the sphere of genomics analysis and lift questions on how some might have sought funding from him.
In his assertion to NCS, Thakuria mentioned he was launched to Epstein by George Church, a high-profile Harvard genomics researcher, as a possible analysis topic for the Personal Genome Project.
Church, who has pioneered gene enhancing with the then-novel CRISPR know-how — used to minimize, add and modify particular genetic sequences — has beforehand been related to Epstein, who emailed with him often and donated funds to his analysis. Church apologized in 2019 for his continued affiliation with Epstein, calling it “nerd tunnel vision” in an interview with STAT.
Church, who has not been accused of any wrongdoing associated to Epstein, didn’t return a request for remark from NCS. The spokesperson for Harvard referred NCS to Church’s remarks from 2019 in response to questions on him.
Some of what Thakuria described in his bill was opaque. The largest single merchandise in the bill was $160,000 for analysis he referred to as “The Venus Project.”
“Jeffrey and [I] briefly discussed a genomic research studying [sic] I’m dubbing the Venus project (he’ll know what this),” Thakuria wrote in the June 2014 invoice. “I can do this for him but doing this work would be greatly aided by having some good bioinformatic infrastructure.”
“[Epstein] mentioned 200 participants being in this project — I can deliver on this ‘Venus’ research,” he added.
In his assertion to NCS, Thakuria mentioned the challenge was “an idea of Mr. Epstein that was very preliminary and never went anywhere.”
“He was interested in the genetics of facial features. There was no funding, and no research.”